Home

Differential
Counter

Flow
Tutorial

 

  
 
Myeloproliferative
neoplasms		 Neoplasms with eosinophilia
(PDGRA/PDGFRB/FGFR1)		 MDS/MPN MDS AML Acute leukemia
ambiguous lineage
Precursor lymphoid
neoplasms		 Mature B cell
neoplasms		 Mature T and NK
neoplasms		 Hodgkin
lymphoma		 Immunodeficiency associated
lymphoproliferative disorders		 Histiocytic and dendritic
cell neoplasms
 

Acute Myeloid Leukemia, Not Otherwise Specified
  Unusual antigen expression abstracts Prognostic abstracts Cytogenetic abstracts Antigen chart
AML, NOS
AML with recurrent genetic abnormalities
AML with myelodyspasia related changes
Therapy related myeloid neoplasms
Myeloid sarcoma
Myeloid proliferations related to Down's Syndrome
Blastic plasmacytoid dendritic cell neoplasm
Article Antigens evaluated

Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.

EMA, MUC1, CD11c, CD14, CD68

Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.

Pax5, Oct-2, Bob.1, t(8;21)(q22;q22)

CD79a is heterogeneously expressed in neoplastic and normal myeloid precursors and megakaryocytes in an antibody clone-dependent manner.

CD79a